Studies the heart in patients hospitalized for acute ischemic stroke
Observes heart health in adults hospitalized with stroke from a blocked blood vessel.
Plain-language title generated from the registry record
Registry title: Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
Key facts
- Where
- Suzhou, ChinaSee the site
Where in China
- The First Affiliated Hospital of Soochow UniversitySuzhou, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Soochow University
- Trial code
- NCT06882577
- Record updated
- 13 May 2025
- Original description
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy.Read full original descriptionShow less
Heart Evaluation of Acute Ischemic Stroke With Reperfusion Therapy
Heart Evaluation of Acute ischemic stroke with Reperfusion Therapy (HEART) is a single-center observational registry evaluating the heart of patients hospitalized for acute ischemic stroke with reperfusion therapy.
This registry aims to establish quantified risk stratification and prognostic models, as well as suggest effective diagnostic and therapeutic strategies.
Inclusion: Written informed consent by patient; Age ≥ 18 years; Acute ischemic stroke (with matching brain lesion on MR imaging); Enrolment within 24 h after onset of stroke-related symptoms.
Exclusion: Pregnancy and / or breast-feeding; Participation in an interventional study; Patients refuse to participate in the research.